Trademark: LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES 1126115
Word
LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES
ID
1126115
Trademark Type
Fancy
Status
Ceased
Not renewed: Renewal fee not paid
Application Date
07 March 2006
Registration Date
07 March 2006
Owner(s)
Novo Nordisk A/S
Service
Goods and Services:
Class 16:
Printed publications related to medical studies and research regarding pharmaceutical preparations for the treatment of diabetes related diseases and disorders
Class 42:
Medical and scientific research, namely, conducting clinical trials and studies for pharmaceutical preparations related to the treatment of diabetes related diseases and disorders and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of diabetes related diseases and disorders
Class 44:
Providing medical information on the efficacy of pharmaceutical preparations for the treatment of diabetes related diseases and disorders

Trademark Alertz ® - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by IP Australia. Copyright of the trademark data resides with IP Australia. ipaustralia.gov.au